Currently Browsing

Our Products

Fesoterodine Fumarate Extended-Release Tablets 4 mg – 30/Bottle

Overview

Reference Brand:
Toviaz®
Therapeutic Class:
Fesoterodine

Specifications

GCN:
99711
Strength:
4 mg
Size:
30
NDC #:
65862076630
TE Code:
AB

Order Information

Case Qty (min order qty):
48
Case Weight (lbs):
4.768

Attributes

Physical Form:
Tablets
Shape:
Tablets
Color:
Light blue
Imprint:
"K46"
Prescribing Info
Product News

July 15, 2026 | Aurobindo Receives FDA Approval for Etodolac Tablets USP, 400 mg and 500 mg ... Read more

Product News

June 24, 2026 | Aurobindo Receives FDA Approval for Icosapent Ethyl Capsules, 1 gram ... Read more

Product News

June 09, 2026 | Aurobindo Receives FDA Approval for Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL ... Read more